GLP-1 medication
at unbeatable prices

Personalized prescription GLP-1 medication, as injectables, tablets or drops.

From $149. Includes medication and prescription. No membership fees ever.

Simple and affordable pricing

Unlimited expert support

No insurance needed

Add to Cart
4.5 Rating | 421 Reviews

CUREX HAS BEEN FEATURED IN

Curex makes it simple

Complete Form

It takes just a few minutes to complete some questions about your medical history.

Provider Review

A medical provider will review your intake and recommend treatment, if appropriate.

Free Shipping

Your medication ships free directly to your door, if prescribed.

Ongoing Support

Get unlimited access to follow-ups, adjustments, and reviews of lab results for best results.

Our GLP-1 injectables

Semaglutide

Weekly injection
From $149. Includes prescription and medication. No membership fee ever.
In Stock (Ships in 1-2 Business Days)
Get started

Tirzepatide

Weekly injection
From $199. Includes prescription and medication. No membership fee ever.
In Stock (Ships in 1-2 Business Days)
Get started
Curex oral dissolving tablets (ODT)Curex oral dissolving tablets (ODT)

Don't like needles?
No problem.

We now offer another way to administer GLP-1 medication: oral dissolving tablets (ODT). No more measuring of medication with syringes and no more needles - instead, you simply dissolve a tablet under the tongue.

No needles

Easy to store and travel with

Precise dosage every time

Our GLP-1 oral dissolving tablets (ODT)

Semaglutide ODT

Daily tablet, dissolve under tongue
From $249. Includes prescription and medication. No membership fee ever.
In Stock (Ships in 1-2 Business Days)
Add to Cart

Tirzepatide ODT

Daily tablet, dissolve under tongue
From $299. Includes prescription and medication. No membership fee ever.
In Stock (Ships in 1-2 Business Days)
Add to Cart

Want the best price?

New! GLP-1 Drops

We now offer another way to take GLP-1 medication: GLP-1 drops. They combine ultimate convenience with the lowest prices in the market.

Better taste and no residue in mouth

The best price for GLP-1 medication

Also perfect for microdosing

Our GLP-1 sublingual drops

Semaglutide Sublingual Suspension

Daily drops, place under tongue
From $149. Includes medication and prescription. No membership fees ever.
In Stock (Ships in 1-2 Business Days)
Add to Cart

Tirzepatide Sublingual Suspension

Daily drops, place under tongue
From $199. Includes medication and prescription. No membership fees ever.
In Stock (Ships in 1-2 Business Days)
Add to Cart

Finally, an online clinic with honest pricing

We need to talk about pricing. We know you have choices. Unfortunately, many of those choice include deceptive pricing. More often than not, it’s almost impossible to figure out the true price of weight loss treatment. We believe you shouldn’t have to read the fine print. Our prices are honest and affordable. We don't have membership fees or other additional charges.

‍

Premium Medication you can trust

Our GLP-1 medication is delivered straight to your doorstep from a state-licensed pharmacy within our reliable network, ensuring you receive your medication when you need it.

Each pharmacy in our network undergoes rigorous third-party testing through FDA and DEA certified labs. These tests focus on four key elements, ensuring both safety and efficacy for our treatments.

GLP-1 treatment tailored to you

Initial Dosage

Your initial medication and dosage are carefully determined by doctors, taking into account your unique health profile. This ensures a personalized and safe treatment plan tailored to your specific needs.

Titration

We gradually adjust your dosage to reach the optimal therapeutic level, ensuring maximum effectiveness while minimizing potential side effects.

Additional Treatments

Our providers may also recommend medications such as metformin or supplements such as vitamin B12. We recognize the importance of managing side effects, so your care plan may include medication to alleviate them.

Curex is one of America’s largest telehealth providers

Together with our partners we have changed the lives of over 300,000 patients. Here’s what some of them have to say:

“Curex has performed beyond my expectations. I am feeling tremendously better and look forward to continuing the treatment.”
Becky D.
"If I could give 6 stars, I would. BEST... BEST… BEST… service.”
Ferdian K.
“The Curex staff has been professional, efficient, and really focused on my individual needs.”
Ana C.

Need assistance? We’re here to help.

Call or Text Us
(857) 240-1080
Email Us
hi@getcurex.com

Important Safety Information for Compounded Semaglutide

‍

Compounded medications, such as semaglutide, may be prescribed by your healthcare provider but are not regulated by the FDA for safety, efficacy, or quality. FDA-approved versions of semaglutide are available.

WARNING

It is imperative to seek immediate medical attention if you experience any of the following serious side effects:

  • Severe nausea or vomiting leading to dehydration: Maintaining proper hydration is critical during treatment with semaglutide.
  • Kidney dysfunction or failure: Nausea, vomiting, and diarrhea can result in dehydration, which may worsen pre-existing kidney conditions and, in some cases, necessitate dialysis.
  • Thyroid C-Cell Tumors: Symptoms such as difficulty swallowing, hoarseness, a lump or swelling in the neck, or shortness of breath should be reported to your physician immediately (see Black Box Warning below).
  • Pancreatitis: Severe and persistent abdominal or back pain may indicate pancreatitis and requires immediate evaluation.
  • Acute gallbladder disease: Symptoms such as pain in the upper right or middle abdomen, fever, yellowing of the skin or eyes, nausea, or vomiting may indicate gallbladder issues, warranting further diagnostic evaluation.
  • Liver complications (hepatitis, elevated liver enzymes, jaundice).
  • Worsening diabetic retinopathy: Changes in vision, particularly in patients with pre-existing diabetic retinopathy, should be closely monitored.
  • Gastrointestinal disorders: This medication is contraindicated in patients with a history of severe gastrointestinal diseases.
  • Symptoms of hypoglycemia: Although uncommon with GLP-1 receptor agonists, hypoglycemia may occur. Signs include dizziness, shaking, sweating, and confusion. In such cases, consuming foods or beverages containing sugar can help restore normal blood sugar levels. Patients on insulin or sulfonylureas (e.g., glipizide, glimepiride, glyburide) should consult their physician about potential dose adjustments to avoid hypoglycemia.
  • Elevated heart rate.
  • Worsening depression or suicidal ideation.

Do not share your semaglutide prescription with others.

Drug Interactions

Compounded semaglutide may interact with alcohol, prescription and non-prescription medications, and herbal supplements. The risk of hypoglycemia increases when used in conjunction with insulin or insulin-stimulating medications (e.g., sulfonylureas). Additionally, semaglutide can slow gastric emptying, affecting the absorption of oral medications. Patients on thyroid medication should consult with their healthcare provider to discuss potential adjustments to their dosing schedule. For medications with narrow therapeutic windows, such as warfarin, close monitoring is essential.

For a comprehensive list of potential side effects, drug interactions, and precautions, please refer to the official pharmaceutical documentation.

To report adverse reactions, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch. In the event of a medical emergency, dial 911 or visit the nearest emergency facility.

Note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Black Box Warning

GLP-1 receptor agonists, including semaglutide, are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Animal studies have demonstrated an increased risk of thyroid tumors, including cancer, although it is uncertain whether these findings apply to humans. Notify your healthcare provider immediately if you develop symptoms such as difficulty swallowing, hoarseness, a lump in your neck, or shortness of breath.

Additional Precautions

  • Alcohol use: Avoid alcohol consumption while using this medication.
  • Contraception: Use appropriate birth control while taking semaglutide. If pregnant, breastfeeding, or planning to conceive, discuss discontinuation of the medication with your healthcare provider at least two months prior to conception, as it may cause harm to the fetus.
  • Medical history: Inform your healthcare provider if you have any history of liver, kidney, or pancreatic conditions.
  • Allergic reactions: If you experience any signs of a severe allergic reaction, such as swelling of the face, lips, tongue, or throat, difficulty breathing, or a rapid heartbeat, seek medical attention immediately. Severe hypersensitivity reactions, including anaphylaxis, have been reported, and the medication should be discontinued if this occurs.

Ensure that you communicate your full medical history with your healthcare provider before initiating treatment with semaglutide.

Important Safety Information for Compounded Tirzepatide

‍

Compounded medications, such as tirzepatide, may be prescribed by your healthcare provider but are not regulated by the FDA for safety, efficacy, or quality. FDA-approved versions of semaglutide are available.

WARNING

The use of compounded tirzepatide may be linked to the potential development of thyroid tumors, including thyroid cancer. Be vigilant for symptoms like lumps or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath. If any of these signs occur, notify your healthcare provider immediately.

Do not use compounded tirzepatide if you or a family member have a history of medullary thyroid carcinoma (MTC), a form of thyroid cancer. It should also be avoided if you have been diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have had a severe allergic reaction to tirzepatide or its ingredients.

Serious Side Effects

There are serious side effects associated with the use of compounded tirzepatide, which may include:

  • Gastrointestinal Issues: Some individuals have reported significant stomach problems with compounded tirzepatide. Contact your healthcare provider if you experience persistent or severe abdominal discomfort.
  • Kidney Issues: Vomiting, diarrhea, or nausea can lead to dehydration, which may result in kidney complications. Ensure adequate hydration to reduce this risk.
  • Gallbladder Problems: Compounded tirzepatide may cause gallbladder issues. Seek medical help immediately if you experience upper stomach pain, fever, jaundice, or changes in stool color.
  • Pancreatitis: If you experience ongoing abdominal pain, with or without vomiting, stop using compounded tirzepatide and contact your healthcare provider immediately, as it may indicate pancreatic inflammation.
  • Allergic Reactions: Stop using the medication and seek urgent medical care if you experience signs of a severe allergic reaction, such as facial swelling, difficulty breathing, hives, or a fast heartbeat.
  • Hypoglycemia: The risk of low blood sugar may increase when using compounded tirzepatide alongside other blood-sugar-lowering medications. Watch for symptoms like dizziness, sweating, confusion, or a racing heartbeat.
  • Vision Changes: Report any changes in vision during treatment to your healthcare provider.
  • Depression or Suicidal Thoughts: Monitor your mental health closely and report any mood changes or suicidal thoughts to your healthcare provider right away.

Common Side Effects

The most common side effects of compounded tirzepatide include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Indigestion
  • Injection site reactions
  • Fatigue
  • Allergic reactions
  • Belching
  • Hair loss
  • Heartburn

This is not a complete list of possible side effects. If you experience any persistent or troubling symptoms, consult your healthcare provider for advice on managing them.

Let your healthcare provider know if you experience any side effects.

To report suspected severe side effects or adverse reactions to compounded tirzepatide, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch. In the event of an emergency, call 911 or visit your nearest emergency room.

Drug Interactions

Like other medications, compounded tirzepatide can interact with alcohol, certain prescription and over-the-counter medications, and herbal products. The risk of hypoglycemia is higher when used with insulin or insulin secretagogues, such as sulfonylureas. Compounded tirzepatide also slows gastric emptying, which may affect how oral medications are absorbed. If you are taking thyroid hormone medications, you may need to adjust the timing of your doses while on compounded tirzepatide. Medications with narrow therapeutic windows (such as warfarin) should be closely monitored during treatment with compounded tirzepatide.

Refer to the product packaging for the full list of side effects, warnings, interactions, and additional information.

Tirzepatide may reduce the effectiveness of birth control pills. Speak to your doctor before starting tirzepatide if you use oral contraceptives. Your doctor may recommend an alternative method of birth control for four weeks after starting tirzepatide and after each dosage increase.

Note: The above information has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Important Safety Information for Compounded Semaglutide

‍

Compounded medications, such as semaglutide, may be prescribed by your healthcare provider but are not regulated by the FDA for safety, efficacy, or quality. FDA-approved versions of semaglutide are available.

WARNING

It is imperative to seek immediate medical attention if you experience any of the following serious side effects:

  • Severe nausea or vomiting leading to dehydration: Maintaining proper hydration is critical during treatment with semaglutide.
  • Kidney dysfunction or failure: Nausea, vomiting, and diarrhea can result in dehydration, which may worsen pre-existing kidney conditions and, in some cases, necessitate dialysis.
  • Thyroid C-Cell Tumors: Symptoms such as difficulty swallowing, hoarseness, a lump or swelling in the neck, or shortness of breath should be reported to your physician immediately (see Black Box Warning below).
  • Pancreatitis: Severe and persistent abdominal or back pain may indicate pancreatitis and requires immediate evaluation.
  • Acute gallbladder disease: Symptoms such as pain in the upper right or middle abdomen, fever, yellowing of the skin or eyes, nausea, or vomiting may indicate gallbladder issues, warranting further diagnostic evaluation.
  • Liver complications (hepatitis, elevated liver enzymes, jaundice).
  • Worsening diabetic retinopathy: Changes in vision, particularly in patients with pre-existing diabetic retinopathy, should be closely monitored.
  • Gastrointestinal disorders: This medication is contraindicated in patients with a history of severe gastrointestinal diseases.
  • Symptoms of hypoglycemia: Although uncommon with GLP-1 receptor agonists, hypoglycemia may occur. Signs include dizziness, shaking, sweating, and confusion. In such cases, consuming foods or beverages containing sugar can help restore normal blood sugar levels. Patients on insulin or sulfonylureas (e.g., glipizide, glimepiride, glyburide) should consult their physician about potential dose adjustments to avoid hypoglycemia.
  • Elevated heart rate.
  • Worsening depression or suicidal ideation.

Do not share your semaglutide prescription with others.

Drug Interactions

Compounded semaglutide may interact with alcohol, prescription and non-prescription medications, and herbal supplements. The risk of hypoglycemia increases when used in conjunction with insulin or insulin-stimulating medications (e.g., sulfonylureas). Additionally, semaglutide can slow gastric emptying, affecting the absorption of oral medications. Patients on thyroid medication should consult with their healthcare provider to discuss potential adjustments to their dosing schedule. For medications with narrow therapeutic windows, such as warfarin, close monitoring is essential.

For a comprehensive list of potential side effects, drug interactions, and precautions, please refer to the official pharmaceutical documentation.

To report adverse reactions, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch. In the event of a medical emergency, dial 911 or visit the nearest emergency facility.

Note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Black Box Warning

GLP-1 receptor agonists, including semaglutide, are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Animal studies have demonstrated an increased risk of thyroid tumors, including cancer, although it is uncertain whether these findings apply to humans. Notify your healthcare provider immediately if you develop symptoms such as difficulty swallowing, hoarseness, a lump in your neck, or shortness of breath.

Additional Precautions

  • Alcohol use: Avoid alcohol consumption while using this medication.
  • Contraception: Use appropriate birth control while taking semaglutide. If pregnant, breastfeeding, or planning to conceive, discuss discontinuation of the medication with your healthcare provider at least two months prior to conception, as it may cause harm to the fetus.
  • Medical history: Inform your healthcare provider if you have any history of liver, kidney, or pancreatic conditions.
  • Allergic reactions: If you experience any signs of a severe allergic reaction, such as swelling of the face, lips, tongue, or throat, difficulty breathing, or a rapid heartbeat, seek medical attention immediately. Severe hypersensitivity reactions, including anaphylaxis, have been reported, and the medication should be discontinued if this occurs.

Ensure that you communicate your full medical history with your healthcare provider before initiating treatment with semaglutide.

Important Safety Information for Compounded Tirzepatide

‍

Compounded medications, such as tirzepatide, may be prescribed by your healthcare provider but are not regulated by the FDA for safety, efficacy, or quality. FDA-approved versions of semaglutide are available.

WARNING

The use of compounded tirzepatide may be linked to the potential development of thyroid tumors, including thyroid cancer. Be vigilant for symptoms like lumps or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath. If any of these signs occur, notify your healthcare provider immediately.

Do not use compounded tirzepatide if you or a family member have a history of medullary thyroid carcinoma (MTC), a form of thyroid cancer. It should also be avoided if you have been diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have had a severe allergic reaction to tirzepatide or its ingredients.

Serious Side Effects

There are serious side effects associated with the use of compounded tirzepatide, which may include:

  • Gastrointestinal Issues: Some individuals have reported significant stomach problems with compounded tirzepatide. Contact your healthcare provider if you experience persistent or severe abdominal discomfort.
  • Kidney Issues: Vomiting, diarrhea, or nausea can lead to dehydration, which may result in kidney complications. Ensure adequate hydration to reduce this risk.
  • Gallbladder Problems: Compounded tirzepatide may cause gallbladder issues. Seek medical help immediately if you experience upper stomach pain, fever, jaundice, or changes in stool color.
  • Pancreatitis: If you experience ongoing abdominal pain, with or without vomiting, stop using compounded tirzepatide and contact your healthcare provider immediately, as it may indicate pancreatic inflammation.
  • Allergic Reactions: Stop using the medication and seek urgent medical care if you experience signs of a severe allergic reaction, such as facial swelling, difficulty breathing, hives, or a fast heartbeat.
  • Hypoglycemia: The risk of low blood sugar may increase when using compounded tirzepatide alongside other blood-sugar-lowering medications. Watch for symptoms like dizziness, sweating, confusion, or a racing heartbeat.
  • Vision Changes: Report any changes in vision during treatment to your healthcare provider.
  • Depression or Suicidal Thoughts: Monitor your mental health closely and report any mood changes or suicidal thoughts to your healthcare provider right away.

Common Side Effects

The most common side effects of compounded tirzepatide include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Indigestion
  • Injection site reactions
  • Fatigue
  • Allergic reactions
  • Belching
  • Hair loss
  • Heartburn

This is not a complete list of possible side effects. If you experience any persistent or troubling symptoms, consult your healthcare provider for advice on managing them.

Let your healthcare provider know if you experience any side effects.

To report suspected severe side effects or adverse reactions to compounded tirzepatide, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch. In the event of an emergency, call 911 or visit your nearest emergency room.

Drug Interactions

Like other medications, compounded tirzepatide can interact with alcohol, certain prescription and over-the-counter medications, and herbal products. The risk of hypoglycemia is higher when used with insulin or insulin secretagogues, such as sulfonylureas. Compounded tirzepatide also slows gastric emptying, which may affect how oral medications are absorbed. If you are taking thyroid hormone medications, you may need to adjust the timing of your doses while on compounded tirzepatide. Medications with narrow therapeutic windows (such as warfarin) should be closely monitored during treatment with compounded tirzepatide.

Refer to the product packaging for the full list of side effects, warnings, interactions, and additional information.

Tirzepatide may reduce the effectiveness of birth control pills. Speak to your doctor before starting tirzepatide if you use oral contraceptives. Your doctor may recommend an alternative method of birth control for four weeks after starting tirzepatide and after each dosage increase.

Note: The above information has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.